InvestorsHub Logo
icon url

bwolfy2002

04/07/20 11:09 AM

#65608 RE: StockBroker42069 #65606

Read the extended headline and the body of the PR.

“Separately, Dr. Pourhassan will appear on Fox Business Network on April 7 at 11:00 am PT to provide a full update on the CytoDyn’s two clinical trials for COVID-19, a Phase 2 trial for those patients with mild-to-moderate indications and a Phase 2b/3 trial for severe and critically ill patients.”


https://www.cytodyn.com/newsroom/press-releases/detail/410/cytodyn-collaborating-with-u-k-s-department-of-health-to
icon url

chumppunk

04/07/20 11:11 AM

#65610 RE: StockBroker42069 #65606

StockBroker32069- From CYDY site- https://www.cytodyn.com/newsroom/press-releases/detail/410/cytodyn-collaborating-with-u-k-s-department-of-health-to

April 7, 2020
CytoDyn Collaborating with U.K.’s
Department of Health to Provide
Emergency Access to Leronlimab for
Severe and Critically Ill COVID-19 Patients
CEO Nader Pourhassan will appear on FOX Business Network on April 7
at 11:00 am PT to provide an update on the Company’s two COVID-19
clinical trials and 15 patients on EIND
VANCOUVER, Washington, April 07, 2020 (GLOBE NEWSWIRE) -- CytoDyn Inc.
(OTC.QB: CYDY), (“CytoDyn” or the “Company"), a late-stage biotechnology company
developing leronlimab (PRO 140), a CCR5 antagonist with the potential for multiple
therapeutic indications, announced today that it is collaborating with the U.K.’s Department
icon url

Bobbythebus

04/07/20 11:13 AM

#65611 RE: StockBroker42069 #65606

Nooooo. It’s today the 7 th got changed
icon url

JPG77

04/07/20 12:31 PM

#65645 RE: StockBroker42069 #65606

Not according to the PR - it's TODAY!